ArticleJournal for immunotherapy of cancer2022

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials.

Espen Basmo Ellingsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.